| GTO ID | GTC0718 |
| Trial ID | ACTRN12622001542785 |
| Disease | Solid Tumor |
| Altered gene | LeY |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | Lewis Y Nivo-CAR-T cells |
| Co-treatment | Nivolumab |
| Phase | Phase1 |
| Recruitment status | Not Recruiting |
| Title | A pilot study of Lewis-Y targeting Chimeric Antigen Receptor T-cells given in combination with Nivolumab in Lewis-Y expressing solid tumours. |
| Year | 2022 |
| Country | Australia |
| Company sponsor | Peter MacCallum Cancer Centre |
| Cohort 1 | |||||||||||
|
|||||||||||